Assess ability of the drug magnesium sulphate when added with a local anaesthesia agent like ropivacaine and compare it to ropivacaine alone to alleviate pain while being continuously given in the post operative surgical site after uterus removal surgery
Phase 3
Completed
- Conditions
- Health Condition 1: null- POST OPEN HYSTERECTOMY
- Registration Number
- CTRI/2017/07/009176
- Lead Sponsor
- AIIMS Intramural Funding
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
a) Female patients 18yrs and above; b) Belonging to ASA physical status 1&2; c) Patients undergoing open hysterectomy for benign conditions
d) Patients operated with a transverse incision
Exclusion Criteria
a) Patients with malignancy;b) On systemic analgesic medication for some other ailment;c) Patients refusal to have catheter;
d) Known allergy to any of the study drugs
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method